Better Ways to Play Biotechnology: Q&A with BioShares (BBC, BBP)

Biotech ETFs were among the best performers in 2014 and the spotlight has remained fixated on this corner of the health care market as investors continue to seek out lucrative growth opportunities. But when it comes to establishing exposure, compared to some other corners of the market, there simply hasn’t been the same level of granularity among the ETFs that are designed to provide access to this segment of the health care industry.